.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Immunotherapy has revolutionized the oncology landscape. However, resistance remains a significant hurdle in gastric cancer treatment. A new study introduces a machine learning model to predict gastric cancer immunotherapy response. This model utilizes single-cell transcriptomics to identify specific cellular determinants of resistance.
The research identifies a unique T/NK cell subset associated with poor outcomes. These cells exhibit impaired MHC-I-mediated immune recognition. Furthermore, they display elevated histidine metabolism and stay at an early differentiation stage. Consequently, these findings offer a new map of the tumor microenvironment. Understanding these cell populations is crucial for refining treatment protocols.
The study highlights the transcription factor IRF1 as a potential suppressor of resistance. Mechanistically, IRF1 inhibits invasion and promotes cancer cell death through apoptosis. Additionally, the developed machine learning model predicts patient responses accurately across two independent cohorts. Notably, the model achieved AUCs of 0.75 and 0.73. Therefore, these insights may guide future personalized therapy strategies. Targeting the T/NK cell subset or restoring IRF1 function represents a promising approach to overcoming resistance.
IRF1 acts as a suppressor of immune resistance. It works by inhibiting the invasion of cancer cells and promoting apoptosis, which enhances the effectiveness of immunotherapy.
The model analyzes single-cell transcriptomic data to identify T/NK cell subsets and metabolic markers. It reached predictive accuracy with AUCs of 0.75 and 0.73 in independent patient groups.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ning W et al. A Single-Cell Guided Machine Learning Model Predicts Response to Immune Checkpoint Inhibitors in Gastric Cancer. J Chem Inf Model. 2026 Jun 11. doi: 10.1021/acs.jcim.6c01090. PMID: 42273856.
Sun K et al. Single-cell transcriptomics in cancer immunotherapy. Journal of Hematology & Oncology. 2024;17(1):15-28.
Chen W et al. IRF1 suppresses gastric tumorigenesis via dual PI3K/AKT-ERK pathway modulation. Cell Oncol (Dordr). 2026 Jan 13;49(1):24. doi: 10.1007/s13402-025-01134-w.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers developed a single-cell guided machine learning model to predict gastric cancer response to immunotherapy. By identifying IRF1 as a key suppressor of resistance and profiling T/NK cell subsets, the study provides a robust tool for personalizing treatment and overcoming drug resistance.
3 months ago
A recent study highlights the utility of two-dimensional speckle tracking echocardiography in assessing right atrial mechanics in OSAHS. Progressive reductions in reservoir and conduit strain, coupled with elevated contraction strain, signal early right heart remodeling correlated with apnea severity.
Today
A multicentre RCT in China shows that the PAICS AI system significantly boosts sonographer sensitivity in detecting fetal intracranial malformations by 8.7% without compromising specificity, offering promising diagnostic support for prenatal neurosonography.
Today
A 2026 meta-analysis evaluates PDE5 inhibitors in advanced ILD with severe gas exchange impairment. While overall mortality was not significantly reduced, a targeted subgroup with pulmonary hypertension showed a 49% risk reduction, underscoring the necessity of precise hemodynamic phenotyping.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Yesterday
The Supreme Court questioned FSSAI's phased warning approach, urging single-phase implementation for foods exceeding limits in any nutrient of concern. Backed by ICMR-NIN recommendations, the proposed red hexagonal warnings target added sugar, salt, and fat to combat India's escalating chronic disease epidemic.
Today
